A study comparing two different strengths of oral therapy in facial dark patches

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: Intervention1: oral tranexamic acid: 250mg once daily for 12weeks Control Intervention1: oral tranexamic acid: 250mg twice daily for 12weeks CONDITION: Health Condition 1: L811‐ Chloasma PRIMARY OUTCOME: reduction in mMASI scoresTimepoint: week 0,4,8,12 SECONDARY OUTCOME: melasma quality of life scaleTimepoint: week 0, 12 patient assessment scaleTimepoint: week 0,12 physican assessment scaleTimepoint: week 0,4,8,12 INCLUSION CRITERIA: off depigmenting agents atleast 4 weeks photoprotection daily
Epistemonikos ID: d6f0399893f87946b4ddaa1766ea4bea2f93f494
First added on: Oct 08, 2026